ANGELA RACHAL: Open Payments
NPI 1386959351 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 55 payments from 19 companies in 2025. Trend: 2023 $19 · 2024 $902 · 2025 $1,031
Food & beverage: $932Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $216 |
| ABBVIE INC. | 15 | $209 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $67 |
| MILLICENT US INC | 3 | $59 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Sumitomo Pharma America, Inc. | 3 | $55 |
| PFIZER INC. | 3 | $53 |
| Exact Sciences Corporation | 3 | $44 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Dexcom, Inc. | 2 | $38 |
Products named: UBRELVY, Veozah, JARDIANCE, Auvelity, INTRAROSA, Dexcom G6 Transmitter, GEMTESA, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
